Do not judge a symptom only by whether it appears on a side-effect list. Its severity, duration and effect on drinking, eating and daily life determine how urgently you need help.
Common does not mean something must be endured
Nausea, vomiting and diarrhoea are recognised with tirzepatide, particularly around dose changes. Tell your prescriber about symptoms that persist, recur or disrupt normal life. You do not have to wait for the next purchase to raise a concern. A review may need to address the treatment plan, other medicines or a cause unrelated to Mounjaro.
Describe what happens rather than labelling it simply as 'bad side effects'. Note how often you vomit, whether you can keep fluids down, whether pain is present and how long it lasts. A record is useful only if it supports getting care; it should never delay assessment of severe symptoms.
Sources: Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: patient information leaflet
Watch for the consequences of fluid loss
Repeated vomiting or diarrhoea can lead to dehydration. Signs include darker urine, urinating less, dizziness and a dry mouth. NHS advice recommends urgent help for concerning features such as persistent dizziness on standing, unusually low urine output or a fast heartbeat. People who cannot keep fluids down need prompt clinical advice.
Tell the clinician about kidney disease, fluid restrictions and other medicines rather than trying to follow a generic drinking target. Record when you last passed urine and what fluids you have managed. If you feel faint or unwell, arrange help instead of driving yourself to collect another prescription.
Severe persistent pain needs urgent assessment
The MHRA strengthened pancreatitis warnings in January 2026. Severe abdominal pain that continues, sometimes radiating to the back and accompanied by nausea or vomiting, needs urgent medical attention. Do not assume that pain is ordinary indigestion because it followed an injection. A clinician must assess the cause; confirmed pancreatitis is a reason not to restart this treatment.
Gallbladder problems can also cause abdominal pain. The NHS advises emergency assessment for sudden severe tummy pain, pain spreading to the back with vomiting, or associated jaundice or high temperature. You cannot distinguish these conditions safely from an online symptom list. Tell the treating team the medicine name and last dose.
Sources: MHRA: GLP-1 medicines: strengthened warnings on acute pancreatitis; NHS: Gallstones: symptoms and urgent help
Your other medicines change the discussion
If you use insulin or a sulfonylurea, the care team should consider low-blood-sugar risk when prescribing tirzepatide. Shaking, sweating, palpitations or confusion need attention according to your diabetes plan. Do not independently reduce or stop insulin because you are eating less; ask the diabetes team for a plan that covers illness and reduced intake.
A serious allergic reaction is an emergency. Call 999 for difficulty breathing, sudden swelling of the lips, mouth, throat or tongue, or collapse. Reporting a side effect through a provider's messaging system is not an alternative to emergency care.
Sources: Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: UK Summary of Product Characteristics; NHS: Low blood sugar: hypoglycaemia; NHS: Anaphylaxis: emergency symptoms and action
Close the loop after a symptom review
Before the consultation ends, confirm what to do about the next scheduled dose, what changes to monitor and when to seek further help. If another clinician treated you urgently, make sure the prescribing service knows the outcome. Keep a copy of any discharge advice alongside the prescription details.
Suspected adverse effects can be reported to the MHRA Yellow Card scheme. Include the brand, dose, timing and other medicines where possible. A report helps medicine safety monitoring; it does not provide individual treatment or prove that the medicine caused the symptom.
Sources: MHRA: GLP-1 medicines for weight loss and diabetes: what you need to know
Questions, answered.
Does nausea prove the treatment is effective?
No. Symptoms should be assessed as symptoms. They are not a target to achieve or a reason to increase the dose.
Sources: Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: patient information leaflet
Should I wait for my online provider to reply to severe pain?
No. Seek urgent medical assessment for severe persistent abdominal pain. Use emergency services for severe or life-threatening symptoms.
Sources: MHRA: GLP-1 medicines: strengthened warnings on acute pancreatitis; NHS: Gallstones: symptoms and urgent help
Sources & further reading
Original sources for this guide. Source checks are not independent clinical review.
- Mounjaro KwikPen: patient information leafletEli Lilly / electronic medicines compendium · Accessed 19 November 2026
- Mounjaro KwikPen: UK Summary of Product CharacteristicsEli Lilly / electronic medicines compendium · Accessed 19 November 2026
- Dehydration: symptoms and when to get helpNHS · Accessed 19 November 2026
- GLP-1 medicines: strengthened warnings on acute pancreatitisMHRA · Accessed 19 November 2026
- Gallstones: symptoms and urgent helpNHS · Accessed 19 November 2026
- Low blood sugar: hypoglycaemiaNHS · Accessed 19 November 2026
- Anaphylaxis: emergency symptoms and actionNHS · Accessed 19 November 2026
- GLP-1 medicines for weight loss and diabetes: what you need to knowMHRA · Accessed 19 November 2026
